Pre-Conference Symposium


Latest updates on the WHO 3rd Global Patient Safety Challenge

“Medication without Harm



Moderator: Rabih Dabliz
Type of Session: Knowledge – Based

Session Program:

Time Speaker Topic
09:00-09:15 Qamra Al-Sarari

Director General of Quality Assurance Center

Key note and Introduction
09:15-09:35 Mondher Letaief, MD, MPH

Regional Adviser, Quality and Safety

Department of Universal Health Coverage Health Systems World Health Organization – EMRO

Updates on the WHO Patient Safety Global Challenge: “Medication without Harm”
09:35-09:50 Lina R. Bader PhD RPharmS Lead for Workforce Transformation & Development at International Pharmaceutical Federation (FIP) Patient & Medication Safety: Pharmacists’ Perspective and Contribution
09:50-10:10 Sara Albalushi Sr. Specialist Pharmacist

Director pharmaceutical Care. MOH.Oman

Ministry of Health Response to Medication without Harm Challenge

“Pharmaceutical Care Initiatives”

10:10-10:40 Coffee Break
10:40-11:00 Thamir M. Alshammari, RPh, Ph.D, M.S, FISoPAdvisor, Saudi Food and Drug uthority Executive President Associate Professor of Pharmacy Practice Senior researcher, Medication Safety Research Chair, King Saud University President, International Society of Pharmacovigilance Middle East

Pharmacoepidemiology and Pharmacovigilance Consultant ,Riyadh KSA

Medication without harm: Saudi Arabia Experiences
11:00-11:20 Mohammed Alshennawi, B.Sc. Pharm., M.B.A. General Director, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia. Shifting Toward Safety Culture – The Saudi Ministry of Health Experience
11:20-11:40 Alpana Mair FFRPS,IP, MRPharmS

Head of Effective Prescribing and Therapeutics, Scottish Government

Scottish Quality, Safety & Improvement Fellow.UK

Addressing Medication Safety in Polypharmacy and High Risk Medications
11:40-12:00 Charlotte Rossing, M Sc (Pharm), PhD.

Director of R&D, Pharmakon, Danish College of Pharmacy Practice. Denmark

Danish Initiatives to Support WHO Initiative “Medication Without Harm” and How to Measure if Success
12:00-12:20 Carolyn Hoffman RN MN
President and CEO Institute for Safe Medication Practices Canada

(ISMP Canada) System. Canada

Responding to the WHO Global Challenge: Reporting, Learning and Engaging to Improve Medication Safety in Canada
12:20-12:40 John Hertig, PharmD, MS, CPPS, FASHP

Associate Professor and Vice-Chair of Pharmacy Practice

Butler University College of Pharmacy and Health Sciences

High-Risk but no Harm: USA Strategies for Using Human Factors Science to Improve Patient Safety.
12:40-13:00 MARK LOCK , BSc, BPharm, MBA, AGIA, AACPA Business Development Manager for Terry White Chemmart Pharmacies


Advances in Medicines Safety :

The role of pharmacists

13:00-13:20 Ciara Kirke

Clinical Lead, National Medication Safety Program, Health Service Executive, Ireland

Partnering with People Using Medicines – the key to Ireland’s Response to the Medication Without Harm Challenge
13:20-13:50 Discussion
13:50-14:50 Lunch